My first research poster at an international conference!! if you’re interested in protein aggregation in Alzheimer’s disease or drugs to inhibit them, reach out! #AAIC24#AAIC2024#AAIC
Everyone's talking about the phase 3 results of #Alzheimers drug Lecanemab presented at #CTAD#CTAD22 and published this evening in the @NEJM. But a really striking subgroup analysis that no one else has pointed out yet (cred. @RoreBole) is that the findings are driven by men!
Last week, BrightFocus hosted 75+ early-career Alzheimer’s researchers from around the world at its annual Alzheimer’s Fast Track workshop in San Diego.
To learn how #AlzFastTrack is making an impact on Alzheimer’s researchers, visit ➡️ https://t.co/CmQhtzARvF
Awwww thank you!! 😂 I always forget to take pictures 🙏 had an excellent time at the conference and I definitely appreciate your leniency with the group questions 😂